428 related articles for article (PubMed ID: 29185676)
1. Effect of physiotherapeutic intervention on the gait after the application of botulinum toxin in children with cerebral palsy: systematic review.
Fonseca PR; Calhes Franco de Moura R; Galli M; Santos Oliveira C
Eur J Phys Rehabil Med; 2018 Oct; 54(5):757-765. PubMed ID: 29185676
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
4. Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review.
Mathevon L; Bonan I; Barnais JL; Boyer F; Dinomais M
Ann Phys Rehabil Med; 2019 Jul; 62(4):283-290. PubMed ID: 30063979
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
Ade-Hall RA; Moore AP
Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of botulinum toxin A lower limb injections in addition to physiotherapy approaches in children with cerebral palsy: A systematic review.
Yana M; Tutuola F; Westwater-Wood S; Kavlak E
NeuroRehabilitation; 2019; 44(2):175-189. PubMed ID: 30856126
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
[TBL] [Abstract][Full Text] [Related]
9. Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review.
Koog YH; Min BI
Clin Rehabil; 2010 Aug; 24(8):685-700. PubMed ID: 20554641
[TBL] [Abstract][Full Text] [Related]
10. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
[TBL] [Abstract][Full Text] [Related]
11. The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy.
Molenaers G; Desloovere K; Fabry G; De Cock P
J Bone Joint Surg Am; 2006 Jan; 88(1):161-70. PubMed ID: 16391261
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
13. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
Preston N; Clarke M; Bhakta B
J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
[TBL] [Abstract][Full Text] [Related]
14. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
15. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.
Kang BS; Bang MS; Jung SH
Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826
[TBL] [Abstract][Full Text] [Related]
16. Use of botulinum toxin A in management of children with cerebral palsy.
Friedman BC; Goldman RD
Can Fam Physician; 2011 Sep; 57(9):1006-73. PubMed ID: 21918142
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.
Graham HK; Aoki KR; Autti-Rämö I; Boyd RN; Delgado MR; Gaebler-Spira DJ; Gormley ME; Guyer BM; Heinen F; Holton AF; Matthews D; Molenaers G; Motta F; García Ruiz PJ; Wissel J
Gait Posture; 2000 Feb; 11(1):67-79. PubMed ID: 10664488
[TBL] [Abstract][Full Text] [Related]
18. The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy.
Preiss RA; Condie DN; Rowley DI; Graham HK
J Bone Joint Surg Br; 2003 Sep; 85(7):943-8. PubMed ID: 14516023
[No Abstract] [Full Text] [Related]
19. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]